---
title: "RGTPQ.US (RGTPQ.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/RGTPQ.US/news.md"
symbol: "RGTPQ.US"
name: "RGTPQ.US"
parent: "https://longbridge.com/en/quote/RGTPQ.US.md"
datetime: "2026-03-17T16:20:20.863Z"
locales:
  - [en](https://longbridge.com/en/quote/RGTPQ.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/RGTPQ.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/RGTPQ.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/RGTPQ.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/RGTPQ.US/news.md)


# RGTPQ.US (RGTPQ.US) — Related News

### [Regener8 Resources launches $2 million pro rata rights issue](https://longbridge.com/en/news/279207746.md)
*2026-03-16T05:37:34.000Z*
> Regener8 Resources launches $2 million pro rata rights issue

### [Regenesys Introduces a New Approach to LinkedIn Growth Focused on Distribution, Not Just Content](https://longbridge.com/en/news/275937299.md)
*2026-02-13T19:00:00.000Z*
> Regenesys, a San Francisco-based marketing technology firm, has launched an AI-driven LinkedIn distribution system aimed

### [Study explores use of Wharton's jelly in plantar fascia care, published by Regenative Labs with Babak Baravarian, DPM.](https://longbridge.com/en/news/274893464.md)
*2026-02-05T00:53:30.000Z*
> In Pensacola, Florida on February 4, 2026, Regenative Labs teamed up with Babak Baravarian, DPM, the Director of Foot &